Top Markets
Coin of the day
Relmada Therapeutics, Inc. Relmada Therapeutics, Inc.

Relmada Therapeutics, Inc.

RLMD
Hisse Senetlerindeki Sıralama #13828
Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company... Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company in the United States. The company focuses on the development of NDV-01, a controlled-release intravesical formulation of gemcitabine and docetaxel, which is in Phase 2 clinical trial for patients with aggressive forms of non-muscle invasive bladder cancer; and Sepranolone, a neurosteroid epimer of allopregnanolone, which is Phase 2b-ready for the potential treatment of prader-willi syndrome, tourette syndrome, excessive tremor, and other diseases related to excessive GABAergic activity. The company has an agreement with Asarina Pharma AB and Trigone. Relmada Therapeutics, Inc. was founded in 2004 and is headquartered in Coral Gables, Florida.
Hisse Fiyatı
$4.36
Piyasa Değeri
$457.32M
Değişim (1 gün)
0.69%
Değişim (1 yıl)
289.29%
Ülke
US
Ticaret Relmada Therapeutics, Inc. (RLMD)

Kategori

Relmada Therapeutics, Inc. (RLMD) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $4.68 - 2026-08-01

Gün sonu en düşük fiyat: $11.43 - 2014-06-01
Relmada Therapeutics, Inc. için hisse fiyatı geçmişi: 2014 - 2026
Yıllık Hisse Fiyatı Performansı
Yıl Performans
2026 (TTM) 10.22%
2025 860.47%
2024 -36.35%
2023 -17.50%
2022 -78.37%
2021 -41.31%
2020 -14.84%
2019 756.21%
2018 52.34%
2017 -6.63%
2016 -71.17%
2015 -80.90%
2014 0.00%
Benzer şirketler veya rakiplerin hisse fiyatı
Şirket Hisse fiyatı Değişim 1yıl% Ülke
$544.38 39.22%
US
$1.03K 45.21%
NL
$121.01 -13.08%
AU
$138.80 476.17%
US
$749.90 5.87%
CH